Navigation Links
Dosage Of Tamiflu Sought To Be Increased

The patients who suffer from bird-flu may require higher doses of Tamiflu, than what Roche Holding AG had recommended, according to officials belonging to the World Health //Organization (WHO). If Tamiflu were to be administered within 48 hours of the symptoms, then the duration and severity of the illness can be reduced.

The drug is being stockpiled across the world to treat the H5N1, in anticipation of a flu pandemic. Clinical trials are due to start in early 2006 in several countries to see if raising the recommended dose by 100% will be more effective on patients. The higher doses are also reportedly safe. Standard recommended doses have failed to cure some patients. The higher dose is being evaluated by the US based National Institutes of Health and WHO with the cooperation of Roche.

The doctors in Vietnam have already been instructed to lengthen the treatment time from 5 days to 7 days for Tamiflu. There have been instances in Asia where patients died in spite of the drug being administered to them, and the reason for this is as yet unknown. One of the reasons for this could be that 48 hours had elapsed before treatment commenced. The Tamiflu trial will involve administering 150 milligrams of the drug for five days, twice a day, instead of the recommended 75 milligrams.

The virus is also reported to be multiplying to higher levels when compared to other normal human viruses, and a resistant virus has also been emerging, making it necessary to administer a higher dosage of the medicine.

A total of 15 localities in Vietnam have already been hit by the virus, leading to the culling of a whole flock of ducks. Across the nation, poultry deaths due to the virus have been reported in 24 localities. Since December 2004, about 22 people in Vietnam have died of the virus. The reports of the outbreaks are hurting the country’s poultry farmers. The monthly losses to the poultry industry are estimated at US$ 44 million, and the media which is controlled by the Government, is being blamed for this for its inaccurate reports.
'"/>




Related medicine news :

1. High-Dosage of Epirubicin and Cyclophosphamide may cause AML
2. Shot Supply: Reduced Dosage of Seasonal flu Vaccine, Works!
3. Heavy Dosage Of Vitamin Supplements May Be Risky For Pregnant Women
4. Dispensing Drug Dosage To Children Through Computers
5. Children Need Different Dosage In Cardiac Arrest
6. Doctors Unaware If Pediatric Dosages Are Safe
7. Tamiflu Shortage Can Be Better Handled By Combining It With Probenecid
8. India To Procure 1 Million Doses Of Tamiflu
9. US Reviews Risks Of Tamiflu After 12 Children Die
10. US Regulator Sees No Link Between Tamiflu And Japan Deaths
11. Roche confirms Tamiflu production talks in US
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... ... , ... “Journey to the Light: The Quest for Happiness and Love. . ... to finding herself. “Journey to the Light: The Quest for Happiness and Love. ... writer of newsletters, manuals, and articles, who has recently decided to expand her literary ...
(Date:7/23/2017)... (PRWEB) , ... July 23, 2017 , ... A ... in St. Louis, and led by the Minneapolis Veterans Administration Health Care System overwhelmingly ... of the disease offers very few benefits. , In the cases involved with ...
(Date:7/23/2017)... ... 23, 2017 , ... Technology is making it easier for ... tools are helping patients become more actively involved in their care and maintaining ... survey, released today by the American Hospital Association’s (AHA) Health Forum. , According ...
(Date:7/23/2017)... ... July 23, 2017 , ... Viora Ltd., a ... US Patent No. 9,038,640 by the United States Patent and Trademark Office. The ... combination of Switching, Vacuum, and Cooling mechanisms to further increase the efficacy and ...
(Date:7/21/2017)... ... July 21, 2017 , ... "As a doctor of lung medicine ... catheters available on the market," said an inventor from Center Valley, Pa. "My idea ... the patient." , He developed the patent-pending PLEURAL SAFE-t-STAT CATHETER KIT to offer an ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/10/2017)... , July 10, 2017 The Institute for ... methods, is the recipient of a VITROCELL® inhalation exposure ... International Science Consortium. The device, which is designed to ... expose human lung cells to airborne test materials in ... use the VITROCELL® system for testing combustible tobacco products, ...
(Date:7/5/2017)... 5, 2017 Wolfmet 3D  printed tungsten collimator manufactured by ... and manufacturing combine to progress molecular radiotherapy imaging. ... are unable to accurately quantify the radiation absorbed by those ... the success of this radiotherapy treatment has been available — ... ...
Breaking Medicine Technology: